Samira Lakhal-Littleton

Functional iron deficiency and outcomes in patients with kidney disease.

Journal: PloS one

Published: October 30, 2025

Hepcidin and Tissue-Specific Iron Regulatory Networks.

Journal: Advances in experimental medicine and biology

Published: July 02, 2025

Iron Deficiency in Cardiovascular Disease　- Diagnosis, Clinical Implications, and Future Directions.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: June 15, 2025

Tissue-Specific Iron Levels Modulate Lipid Peroxidation and the FLASH Radiotherapy Effect.

Journal: bioRxiv : the preprint server for biology

Published: June 04, 2025

Tissue-specific iron levels modulate lipid peroxidation and the FLASH radiotherapy effect.

Journal: Cell death & disease

Published: April 04, 2025

Changes in platelet count as a marker of myocardial iron uptake after administration of ferric carboxymaltose in patients with heart failure.

Journal: Scientific reports

Published: March 09, 2025

Anaemia, neurohormonal activation, and myocardial iron depletion in heart failure: can this vicious circle be broken?

Journal: European heart journal

Published: February 05, 2025

Baseline serum ferritin predicts myocardial iron uptake following intravenous iron therapy - a hypothesis-generating study.

Journal: European journal of heart failure

Published: January 10, 2025

Myocardial iron intake following intravenous iron therapy with ferric carboxymaltose is sustained at 1 year despite recurrence of iron deficiency.

Journal: British journal of haematology

Published: September 20, 2024

Intravenous iron for the treatment of iron deficiency in adults with cystic fibrosis: a prospective observational cohort study.

Journal: The European respiratory journal

Published: June 25, 2024

Intravenous iron therapy results in rapid and sustained rise in myocardial iron content through a novel pathway.

Journal: European heart journal

Published: January 12, 2024

Iron deficiency and supplementation in heart failure.

Journal: Nature reviews. Cardiology

Published: January 08, 2024

Functional iron deficiency and outcomes in patients with kidney disease.

Functional iron deficiency and outcomes in patients with kidney disease.

Hepcidin and Tissue-Specific Iron Regulatory Networks.

Hepcidin and Tissue-Specific Iron Regulatory Networks.

Iron Deficiency in Cardiovascular Disease - Diagnosis, Clinical Implications, and Future Directions.

Iron Deficiency in Cardiovascular Disease - Diagnosis, Clinical Implications, and Future Directions.

Tissue-Specific Iron Levels Modulate Lipid Peroxidation and the FLASH Radiotherapy Effect.

Tissue-Specific Iron Levels Modulate Lipid Peroxidation and the FLASH Radiotherapy Effect.

Tissue-specific iron levels modulate lipid peroxidation and the FLASH radiotherapy effect.

Tissue-specific iron levels modulate lipid peroxidation and the FLASH radiotherapy effect.

Changes in platelet count as a marker of myocardial iron uptake after administration of ferric carboxymaltose in patients with heart failure.

Changes in platelet count as a marker of myocardial iron uptake after administration of ferric carboxymaltose in patients with heart failure.

Anaemia, neurohormonal activation, and myocardial iron depletion in heart failure: can this vicious circle be broken?

Anaemia, neurohormonal activation, and myocardial iron depletion in heart failure: can this vicious circle be broken?

Baseline serum ferritin predicts myocardial iron uptake following intravenous iron therapy - a hypothesis-generating study.

Baseline serum ferritin predicts myocardial iron uptake following intravenous iron therapy - a hypothesis-generating study.

Myocardial iron intake following intravenous iron therapy with ferric carboxymaltose is sustained at 1 year despite recurrence of iron deficiency.

Myocardial iron intake following intravenous iron therapy with ferric carboxymaltose is sustained at 1 year despite recurrence of iron deficiency.

Intravenous iron for the treatment of iron deficiency in adults with cystic fibrosis: a prospective observational cohort study.

Intravenous iron for the treatment of iron deficiency in adults with cystic fibrosis: a prospective observational cohort study.

Intravenous iron therapy results in rapid and sustained rise in myocardial iron content through a novel pathway.

Intravenous iron therapy results in rapid and sustained rise in myocardial iron content through a novel pathway.

Iron deficiency and supplementation in heart failure.

Iron deficiency and supplementation in heart failure.

Iron Deficiency in Cardiovascular Disease　- Diagnosis, Clinical Implications, and Future Directions.

Iron Deficiency in Cardiovascular Disease　- Diagnosis, Clinical Implications, and Future Directions.